Deutsche Bank
VRCA icon

Deutsche Bank’s Verrica Pharmaceuticals VRCA Stock Holding History

Deutsche Bank’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-59
Closed -$260 – 3747
2025
Q1 		$260 Hold
59
– – ﹤0.01% 3578
2024
Q4 		$414 Hold
59
– – ﹤0.01% 3581
2024
Q3 		$857 Sell
59
-18,143
-100% -$817K ﹤0.01% 3581
2024
Q2 		$1.33M Sell
18,202
-155
-0.8% -$11.9K ﹤0.01% 1853
2024
Q1 		$1.09M Buy
18,357
+9,802
+115% +$541K ﹤0.01% 1983
2023
Q4 		$626K Buy
8,555
+8,544
+77,673% +$351K ﹤0.01% 2263
2023
Q3 		$443 Buy
+11
New +$559 ﹤0.01% 3677
2022
Q2 		– Sell
-732
Closed -$60K – 4342
2022
Q1 		$60K Sell
732
-84
-10% -$6.92K ﹤0.01% 3775
2021
Q4 		$75K Buy
816
+42
+5% +$4.76K ﹤0.01% 3823
2021
Q3 		$97K Sell
774
-32
-4% -$3.59K ﹤0.01% 3916
2021
Q2 		$91K Sell
806
-25
-3% -$3.03K ﹤0.01% 4172
2021
Q1 		$126K Sell
831
-75
-8% -$10.4K ﹤0.01% 3855
2020
Q4 		$104K Buy
906
+251
+38% +$23.1K ﹤0.01% 3828
2020
Q3 		$51K Buy
655
+61
+10% +$5K ﹤0.01% 3888
2020
Q2 		$65K Buy
594
+175
+42% +$20.2K ﹤0.01% 3679
2020
Q1 		$46K Sell
419
-26
-6% -$3.42K ﹤0.01% 3586
2019
Q4 		$69K Buy
445
+89
+25% +$13.1K ﹤0.01% 3779
2019
Q3 		$51K Sell
356
-634
-64% -$70.6K ﹤0.01% 3924
2019
Q2 		$114K Sell
990
-356
-26% -$33.4K ﹤0.01% 4143
2019
Q1 		$144K Buy
1,346
+588
+78% +$67.8K ﹤0.01% 4175
2018
Q4 		$61K Sell
758
-560
-42% -$68K ﹤0.01% 4407
2018
Q3 		$214K Buy
+1,318
New +$225K ﹤0.01% 4208

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank's VRCA Position: Q2 2025 in Review

Deutsche Bank sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 59 shares — an estimated $260 sold.

Deutsche Bank first reported a position in VRCA in Q3 2018 and held it in 22 quarters. The position peaked at $1.33M in Q2 2024. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Deutsche Bank reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 59 Verrica Pharmaceuticals shares in Q2 2025, an estimated $260.
  • Deutsche Bank first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 22 quarters.
  • Deutsche Bank's Verrica Pharmaceuticals position peaked at $1.33M in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.